Estudio de fase 3, aleatorizado, doble ciego, para investigar la eficacia y seguridad de LY3502970 administrado una vez al día por vía oralen comparación con placebo en participantes adultos con obesidad o sobrepeso con comorbilidades relacionadas con e/ peso (ATTAIN-1)",

Datos básicos

Código:
J2A-MC-GZGP
Protocolo:
J2A-MC-GZGP
EUDRACT:
2022-502839-19-00
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2023
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

LILLY, S.A.

Resultados del Ensayo Clínico


[Translated article] Knowledge of biological therapy in patients with immune-mediated diseases. BIOINFO study.

Segui-Solanes, Carlos; (...); Borras-Blasco, Joaquin

Article. 10.1016/j.farma.2024.08.002. 2024

  • Open Access.

[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024

  • Open Access.

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes.

Cuerda Del Pino A; (...); Bondia J

Article. 10.1089/dia.2023.0535. 2024


BANFF 2022 PANCREAS TRANSPLANTATION MULTIDISCIPLINARY REPORT: Refinement of guidelines for TCMR, AMR, islet and non-rejection pathologies. Assessment of duodenal cuff biopsies and non-invasive diagnostic methods.

Drachenberg, Cinthia B.; (...); Odorico, Jon

Article. 10.1016/j.ajt.2023.10.011. 2023


Beneficios del uso de un algoritmo de pruebas recomendadas para el diagnóstico y manejo dietético-nutricional del paciente con trastornos gastrointestinales crónicos.

Celi A; (...); Merino Torres JF

Article. 10.20960/nh.04518. 2023


Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Pérez-Alenda S; (...); Núñez-Cortés R

Article. 10.1111/hae.14988. 2024


Cost-effectiveness and cost-utility analysis of haemate-P versus other von willebrand disease treatments in Spain.

Megias-Vericat, Juan E; (...); Yan, Songkai

Article. 10.1080/13696998.2025.2474886. 2025


Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain

Merino-Torres, Juan Francisco; (...); Norman, Gregory

Article. 10.2147/CEOR.S483459. 2024

  • Open Access.

CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Sanchis-Pascual, David; (...); Merino-Torres, Juan Francisco

Article. 10.3390/cancers16101799. 2024


Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Megias-Vericat, J E; (...); Poveda Andres, J L

Letter. 10.1016/j.thromres.2024.109122. 2024


Food-Intolerance Genetic Testing: A Useful Tool for the Dietary Management of Chronic Gastrointestinal Disorders.

Celi, Alexandra; (...); Merino-Torres, Juan F.

Article. 10.3390/nu16162741. 2024


Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

de Lucas, Maria Dolores Garcia; (...); Morales, Cristobal

Article. 10.3389/fendo.2023.1240279. 2023


Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.

Rodríguez MA; (...); Chimeno-Hernández A

Article. 10.1016/j.thromres.2024.109181. 2024


New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024


Nutritional Assessment in Outpatients with Heart Failure.

López Guillén R; (...); Merino Torres JF

Article. 10.3390/nu16172853. 2024


Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study.

Del Olmo-Garcia, Maribel; (...); Argente Pla, Maria

Article. 10.1093/oncolo/oyae343. 2025


Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Phase Angle and Ultrasound Assessment of the Rectus Femoris for Predicting Malnutrition and Sarcopenia in Patients with Esophagogastric Cancer: A Cross-Sectional Pilot Study.

Vieira Maroun, Erika; (...); Merino-Torres, Juan Francisco

Article. 10.3390/nu17010091. 2024

  • Open Access.

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).

Caballero Mateos I; (...); Morales-Portillo C

Article. 10.3390/nu16152545. 2024


Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.

Duran-Martinez, Maria; (...); Martinez-Montoro, Jose Ignacio

Article. 10.1016/j.diabet.2023.101501. 2023


Simultaneous pancreas-kidney transplantation: which graft warns the most?

Giuliani, Tommaso; (...); Andujar, Rafael Lopez

Article. 10.1007/s00423-023-02876-7. 2023


Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Campos de estudio

Compartir